Amylyx Pharmaceuticals, Inc. - Common Stock (AMLX)

While the technology sector – especially regarding artificial intelligence – may have captured the spotlight, investors ought to consider adding healthcare stocks to their portfolio.…

3 Top-Rated Biotech Stocks That Analysts Are Loving Now

By Chris Markoch, InvestorPlace Contributor Nov 28, 2023

Investing in biotech stocks can be tricky, but analysts have bullish outlooks on these three, promising companies.

3 Up-and-Coming Biotech Stocks to Put on Your Must-Buy List

By Chris Markoch, InvestorPlace Contributor Aug 28, 2023

Here are some intriguing up-and-coming biotech stocks that may reward risk-tolerant investors with a long-term outlook.

3 Biotech Stocks to Buy Before Drug Trials End

By John Blankenhorn, InvestorPlace Contributor Jul 28, 2023

Drug trials are a chance for high risk, high reward investing. These stocks doing neurodegenerative trials could be set for big gains.

7 Biotech Stocks to Buy for 100% Returns

By Josh Enomoto, InvestorPlace Contributor Apr 9, 2023

If you can handle the risks associated with high volatility, these biotech stocks to buy might double the returns in your portfolio.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Mar 14, 2023

We're starting off the day with an overview of the biggest pre-market stock movers investors need to keep an eye on for Tuesday!

AMLX Stock Alert: Amylyx Pharma Gains on Huge FDA Win

By Joel Baglole, InvestorPlace Contributor Sep 30, 2022

Shares of Amylyx Pharma are popping today on news that the FDA has greenlit its treatment against the deadly disease ALS.

Why Is Amylyx Pharmaceuticals (AMLX) Stock Up 70% Today?

By William White, InvestorPlace Writer Sep 8, 2022

Amylyx Pharmaceuticals (AMLX) stock is rocketing higher on Thursday following an update from the FDA on its ALS treatment.

7 Biotech Stocks to Buy for Q3

By Shanthi Rexaline Jul 18, 2022

These biotech stocks could be good buys due for a few reasons, including great R&D pipelines and treatments with promising market potential.

Amylyx (AMLX) Stock Spikes 13% as FDA Resumes Discussion of ALS Drug

By David Moadel, InvestorPlace Contributor Jul 5, 2022

A new wrinkle in the story of Amylyx Pharmaceuticals' ongoing battle against ALS bodes well for patients, and for AMLX stock holders.

Why Is Amylyx Pharmaceuticals (AMLX) Stock Up 23% Today?

By William White, InvestorPlace Writer Jun 3, 2022

Amylyx Pharmaceuticals (AMLX) stock is rising higher on Friday following an update from the U.S. Food and Drug Administration (FDA).

7 Biotech Stocks With Key Catalysts in March

By Shanthi Rexaline Mar 9, 2022

These seven stocks have some key catalysts lined up for March with the potential to move their price actions in big ways.

Amylyx Plummets as ALS Drug Fails to Benefit Patients in Trial

From Bloomberg Mar 8, 2024

Amylyx Pharmaceuticals Inc. plummeted in early trading as its drug for amyotrophic lateral sclerosis failed to benefit patients with the paralyzing nerve disease in a trial, suggesting that US regulators may have approved an ineffective treatment.

Amylyx stock climbs after Q4 revenue beat (NASDAQ:AMLX)

From Seeking Alpha Feb 22, 2024

Amylyx Pharmaceuticals (AMLX) stock rises as the company surpasses revenue estimates and updates its timeline for a key late-stage program. Read more here.

Amylyx Pharmaceuticals GAAP EPS of $0.07 misses by $0.16, revenue of $108.4M beats by $1.36M (NASDAQ:AMLX)

From Seeking Alpha Feb 22, 2024

Amylyx Pharmaceuticals reported fourth-quarter and full-year financial results for 2023.

3 small-cap biotechs with potential breakthroughs in 2024

From MarketBeat Feb 6, 2024

These small-cap biotech stocks feature large addressable markets combined with positive analyst sentiment and potential breakthroughs in 2024.

3 Under-the-Radar Biotech Stocks to Buy in 2023

From The Motley Fool Oct 19, 2023

These three lesser-known biotech companies are profitable and growing revenue.

2 Incredible Growth Stocks Near 52-Week Lows to Buy Now

From The Motley Fool Oct 10, 2023

These two high-tech bio companies may be too cheap to ignore right now.

Amylyx Pharmaceuticals, Inc. - Common Stock (AMLX)

AMLX Stock Earnings: Amylyx Pharma Misses EPS, Misses Revenue for Q1 2024

3 Pharma Stocks to Sell in March Before They Crash & Burn

The Top 3 Biotech Stocks to Buy in March 2024

7 Oversold Russell 2000 Stocks to Add to Your February Buy List

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Amylyx Pharmaceuticals, Inc. - Common Stock (AMLX)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

AMLX Stock Predictions, Articles, and Amylyx Pharmaceuticals, Inc. - Common Stock News

Subscriber Sign in